Michael Bagel News Today

The Risk Adjustment Data Validation rule, which CMS is expected to finalize Feb. 1, would have significant financial implications for insurers and their provider partners.

Nearly half of Medicare Advantage plans’ directories contain inaccuracies, according to the most recent federal review.

Once the federal supply of coronavirus vaccines and treatments runs out, health insurers, employers and pharmacy benefit managers must start negotiating with drug manufacturers over prices.

Easing access to coronavirus tests is part of President Joe Biden's pandemic response plan.

A family of four would be able to have 32 home tests covered by their health plan each month.

Stakeholder optimism about CMS' proposal to help exchange plans better predict their expenses for healthy enrollees varies.